Nickel monoxide [1]; nickel oxide [2]; bunsenite [3]
Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] ist in Anhang II als verbotener Stoff für kosmetische Mittel aufgeführt, die in der EU in Verkehr gebracht werden.
Eintragsdetails
Chemische Bezeichnung
Nickel monoxide [1]; nickel oxide [2]; bunsenite [3]
Chemische / IUPAC-Bezeichnung
Nickel monoxide [1]; nickel oxide [2]; bunsenite [3]
Regulatorische Informationen
Weitere Richtlinien
(EC) 2009/790
SCCS-Gutachten
- Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic, Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECC
- Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic, Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EEC
CMR
| Kategorie | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 1A | ✓ | — | — |
Kerndaten
Chemische Identität und Eigenschaften

Nickel trioxide
Nickel Oxide can cause cancer according to California Labor Code. — California Office of Environmental Health Hazard Assessment (OEHHA)
- IUPAC-Name
- oxonickel
- Summenformel
- NiO
- Molekulargewicht
- 74.693 g/mol
- Exakte Masse
- 73.930256 Da
- Topologische polare Oberfläche
- 17,1 Ų
- Wasserstoffbrücken-Donoren
- 0
- Wasserstoffbrücken-Akzeptoren
- 1
- Kovalente Einheiten
- 1
- Definierte Stereozentren
- 0
Auch bekannt als
16 weitere gemeldete Namen
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Physical Description: Dry Powder Quelle: EPA Chemical Data Reporting (CDR)
- Physical Description: Black powder; Insoluble in water; [BDH Laboratory Supplies MSDS] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Carcinogen Classification: 1, carcinogenic to humans. (L135) Quelle: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Inhalation (L41) ; oral (L41) ; dermal (L41) Quelle: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral (L41) ; inhalation (L41) ; dermal (L41) Quelle: Toxin and Toxin Target Database (T3DB)
- Signal: Danger Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H350i: May cause cancer by inhalation [Danger Carcinogenicity]; H372 **: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H413: May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Precautionary Statement Codes: P203, P260, P261, P264, P270, P272, P273, P280, P302+P352, P318, P319, P321, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H350 (98.9%): May cause cancer [Danger Carcinogenicity]; H372 (99.4%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H413 (99.4%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P260, P261, P264, P270, P272, P273, P280, P302+P352, P318, P319, P321, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 179 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H350i: May cause cancer by inhalation [Danger Carcinogenicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Precautionary Statement Codes: P203, P260, P261, P264, P270, P272, P280, P302+P352, P318, P319, P321, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Health Effects: The most common harmful health effect of nickel in humans is an allergic reaction. This usually manifests as a skin rash, although some people experience asthma attacks. Long term inhahation of nickel causes chronic bronchitis and reduced lung function, as well as damage to the naval cavity. Ingestion of excess nickel results in damage to the stomach, blood, liver, kidneys, and immune system, as well as having adverse effects on reproduction and development. (L41) Quelle: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: Nickel is known to substitute for other essential elements in certain enzmes, such as calcineurin. It is genotoxic, and some nickel compounds have been shown to promote cell proliferation. Nickel has a high affinity for chromatin proteins, particularly histones and protamines. The complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. Nickel has also been shown to alter several transcription factors, including hypoxia-inducible transcription factor, activating transcription factor, and NF-KB transcription factor. There is also evidence that nickel ions inhibit DNA repair, either by directly inhibiting DNA repair enzymes or competing with zinc ions for binding to zinc-finger DNA binding proteins, resulting in structural changes in DNA that prevent repair enzymes from binding. Nickel ions can also complex with a number of cellular ligands including amino acids, peptides, and proteins resulting in the generation of oxygen radicals, which induce base damage, DNA strand breaks, and DNA protein crosslinks. (L41, Quelle: Toxin and Toxin Target Database (T3DB)
- Consumer Uses: Other Quelle: EPA Chemical Data Reporting (CDR)
- Industry Uses: Other Quelle: EPA Chemical Data Reporting (CDR)
- Uses: Nickel oxide is used in the production of alloys. It is also used in the ceramic industry to make frits, ferrites, and porcelain glazes, and is a component of the nickel-iron battery and fuel cells. (L46) Quelle: Toxin and Toxin Target Database (T3DB)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-09-02 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.

Nickel Monoxide
Nickel Monoxide is a green to black colored, inorganic compound that turns yellow and produces toxic gases upon heating. Nickel monoxide is used in the electronics, ceramics, steel and alloy industries. Exposure to this substance can cause severe dermatitis, skin and asthma-like allergies and damages the lungs, kidneys, gastrointestinal tract and neurological system. Nickel monoxide is a known carcinogen and is associated with an increased risk of developing lung and nasal cancers. (NCI05) — NCI Thesaurus (NCIt)
- IUPAC-Name
- nickel(2+);oxygen(2-)
- Summenformel
- NiO
- Molekulargewicht
- 74.693 g/mol
- Exakte Masse
- 73.930256 Da
- Topologische polare Oberfläche
- 1,0 Ų
- Wasserstoffbrücken-Donoren
- 0
- Wasserstoffbrücken-Akzeptoren
- 1
- Kovalente Einheiten
- 2
- Definierte Stereozentren
- 0
Auch bekannt als
4 weitere gemeldete Namen
Kennungen in externen Datenbanken
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Density: 6.7 g/cm³ Quelle: ILO-WHO International Chemical Safety Cards (ICSCs)
- Melting Point: 1955 °C Quelle: ILO-WHO International Chemical Safety Cards (ICSCs)
- Physical Description: Large Crystals; CBI; Dry Powder; Other Solid; Liquid; Other Solid; Dry Powder; Other Solid; Dry Powder; Large Crystals Quelle: EPA Chemical Data Reporting (CDR)
- Physical Description: Green solid, insoluble in water; [Merck Index] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: GREEN-TO-BLACK CRYSTALLINE POWDER. Quelle: ILO-WHO International Chemical Safety Cards (ICSCs)
- Solubility: Solubility in water, mg/l at 20 °C: 1.1 (practically insoluble) Quelle: ILO-WHO International Chemical Safety Cards (ICSCs)
- Substance: Nickel (II) Oxide Quelle: NTP Technical Reports
- NTP Technical Report: TR-451: Toxicology and Carcinogenesis Studies of Nickel Oxide (CASRN 1313-99-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (1996 ) Quelle: NTP Technical Reports
- Peer Review Date: 11/29/94 Quelle: NTP Technical Reports
- Conclusion for Male Rat: Some Evidence Quelle: NTP Technical Reports
- Conclusion for Female Rat: Some Evidence Quelle: NTP Technical Reports
- Conclusion for Male Mice: No Evidence Quelle: NTP Technical Reports
- Conclusion for Female Mice: Equivocal Evidence Quelle: NTP Technical Reports
- Summary: Under the conditions of these 2-year inhalation studies, there was some evidence of carcinogenic activity of nickel oxide in male F344/N rats based on increased incidences of alveolar/bronchiolar adenoma or carcinoma (combined) and increased incidences of benign or malignant pheochromocytoma (combined) of the adrenal medulla. There was some evidence of carcinogenic activity of nickel oxide in female F344/N rats based on increased incidences of alveolar/bronchiolar adenoma or carcinoma (combined) and increased incidences of benign pheochromocytoma of the adrenal medulla. There was no evidence of carcinogenic activity of nickel oxide in male B6C3F1 mice exposed to 1.25, 2.5, or 5 mg/m3. There was equivocal evidence of carcinogenic activity of nickel oxide in female B6C3F1 mice based on marginally increased incidences of alveolar/bronchiolar adenoma in 2.5 mg/m3 females and of alveolar/bronchiolar adenoma or carcinoma (combined) in 1.25 mg/m3 females.; Exposure of rats to nickel oxide by inhalation for 2 years resulted in inflammation and pigmentation in the lung, lymphoid hyperplasia and pigmentation in the bronchial lymph nodes, and hyperplasia of the adrenal medulla (females). Expo Quelle: NTP Technical Reports
- Exposure Routes: The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. Quelle: ILO-WHO International Chemical Safety Cards (ICSCs)
- Signal: Danger Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H350i: May cause cancer by inhalation [Danger Carcinogenicity]; H372 **: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H413: May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Precautionary Statement Codes: P203, P260, P261, P264, P270, P272, P273, P280, P302+P352, P318, P319, P321, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement) Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H332 (13.5%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H334 (17.5%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H350 (67.8%): May cause cancer [Danger Carcinogenicity]; H350i (32.3%): May cause cancer by inhalation [Danger Carcinogenicity]; H360 (16.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H372 (99.7%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H401 (20.2%): Toxic to aquatic life [Hazardous to the aquatic environment, acute hazard]; H411 (20.2%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]; H413 (79.8%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P233, P260, P261, P264, P270, P271, P272, P273, P280, P284, P302+P352, P304+P340, P317, P318, P319, P321, P333+P317, P342+P316, P362+P364, P391, P403, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 2079 reports by companies from 51 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: NITE-CMC
- GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H350: May cause cancer [Danger Carcinogenicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: NITE-CMC
- Precautionary Statement Codes: P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P302+P352, P304+P340, P318, P319, P321, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement) Quelle: NITE-CMC
- Signal: Danger Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H350i: May cause cancer by inhalation [Danger Carcinogenicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Consumer Uses: Catalyst; Pigment; Adsorbent; Other Quelle: EPA Chemical Data Reporting (CDR)
- Industry Uses: Catalyst; Not Known or Reasonably Ascertainable; Intermediate; Pigment; Other; Intermediates Quelle: EPA Chemical Data Reporting (CDR)
- Sources/Uses: Used in painting porcelain, electroplating, and glass coloring; Also used to make fuel cell electrodes, ferrites (e.g. NiOFe2O3), nickel salts, nickel catalysts, varistors, and propellant for automotive air bags; [HSDB] Found in the mineral bunsenite; Used in porcelain paint; [Merck Index] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Electroplating [Category: Plate]; Semiconductor Manufacturing [Category: Industry]; Painting (Pigments, Binders, and Biocides) [Category: Paint]; Mining [Category: Industry]; Glass Manufacturing [Category: Industry] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-09-02 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.
Verwandte Einträge zu Nickel monoxide [1]; nickel oxide [2]; bunsenite [3]
Für diesen Eintrag gibt es nur wenige direkte Treffer; daher werden auch nahe liegende Einträge aus Anhang II angezeigt.
6-(2-Chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane
Trinickel disulfide; nickel subsulfied [1]; heazlewoodite [2]
Verbena essential oils (Lippia citriodora Kunth.) and derivatives other than absolute when used as …
Tetracarbonylnickel
3,6,10-Trimethyl-3,5,9-undecatrien-2-one (Pseudo-Isomethyl ionone), when used as a fragrance ingred…
Nickel (II) sulfide [1]; nickel sulfide [2]; millerite[3]
2-Pentylidenecyclohexanone, when used as a fragrance ingredient
Was Anhang II für Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] bedeutet
Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] ist in Anhang II der EU-Kosmetikverordnung (EG) Nr. 1223/2009 als verbotener Stoff aufgeführt und darf nicht absichtlich zugesetzt werden. Artikel 17 regelt gesondert unbeabsichtigte geringe Mengen, die bei guter Herstellungspraxis technisch unvermeidbar und mit der Sicherheitsanforderung nach Artikel 3 vereinbar sind.
Rezepturentwickler müssen ihre Inhaltsstoffe und Rohstoffe prüfen, um sicherzustellen, dass keiner davon diesen Stoff enthält. Lieferanten sollten auf Anfrage eine Dokumentation vorlegen, die die Abwesenheit bestätigt.
Die Seite zeigt außerdem 12 verwandte Anhangseinträge mit überschneidenden Kennungen, Anhangslogik oder Namensmustern.
Compliance-Checkliste
- Prüfen Sie, dass dieser Stoff in allen Rohstoffen und fertigen Rezepturen nicht enthalten ist.
- Fordern Sie von Rohstofflieferanten eine Abwesenheitsbestätigung oder ein Analysenzertifikat an.
- Dokumentieren Sie das Prüfergebnis in der Produktinformationsdatei (PIF).
- Dieser Stoff hat eine CMR-Einstufung. Prüfen Sie die CMR-Tabelle oben und den aktuellen Status nach Anhang II/III, bevor Sie ihn verwenden.
Häufig gestellte Fragen
Quellenhinweis zu Anhang II, Eintrag Nickel monoxide [1]; nickel oxide [2]; bunsenite [3]
Diese Seite fasst einen Eintrag aus Anhang II für Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] aus öffentlichen Materialien der Europäischen Kommission zu kosmetischen Mitteln zusammen und ergänzt, soweit verfügbar, verknüpfte Treffer aus dem Verzeichnis oder bei Kennungen.
Nutzen Sie diese Eintragsseite, um die Bedingungen aus Anhang II für Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] zu prüfen; bestätigen Sie jede endgültige regulatorische Entscheidung jedoch anhand des aktuellen amtlichen Anhangswortlauts und der Quelldateien.
Werkzeuge und nächste Schritte
Rezeptur prüfen
Fügen Sie eine vollständige INCI-Liste ein, um Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] und andere markierte EU-Anhangseinträge in einem Durchgang zu finden.
INCI-CheckerEinträge vergleichen
Nickel monoxide [1]; nickel oxide [2]; bunsenite [3] nebeneinander mit einem anderen Anhangseintrag vergleichen, um Unterschiede bei Beschränkungen, Konzentrationen und Anhangszuordnung zu prüfen.
VergleichenDen Anhang durchsuchen
Alle Einträge in Anhang II ansehen und die regulatorischen Bedingungen der Stoffe in diesem Anhang vergleichen.
Anhang II öffnen